Form 4: ORA insider SAR exercise and share sales reduce stake to 4,861
Rhea-AI Filing Summary
Insider activity summary: Director Stanley Stern exercised 1,210 stock appreciation rights (SARs) with an exercise price of $76.87, based on SARs that expire November 6, 2025. The exercise used the market value on the exercise date of $94.83 to determine payout, resulting in issuance of 229 common shares and a cash settlement for the remaining economic value equivalent to 981 shares. On the same day, 229 shares were sold at $94.83, and an additional 400 shares were sold on September 30, 2025 at $95.98. After these transactions, Mr. Stern beneficially owned 4,861 shares.
Positive
- Full disclosure provided on SAR exercise, share issuance, sales, prices, and resulting beneficial ownership
- Transactions reported within required Section 16 format, including exercise price, market price, and counts
Negative
- None.
Insights
TL;DR: Routine SAR exercise followed by partial sales; reduces insider stake slightly but appears to be standard liquidity activity.
The reporting shows a full exercise of 1,210 SARs at an exercise price of $76.87, with the economic spread calculated against a market price of $94.83. The filing reports both cash settlement (difference equivalent to 981 shares) and issuance of 229 shares, which were subsequently sold the same day, plus an additional sale of 400 shares on 09/30/2025. The transactions reduced beneficial ownership to 4,861 shares. These are material to share count disclosure but do not, by themselves, indicate a change in company control or strategy.
TL;DR: Disclosure is complete for the SAR exercise and subsequent sales; filings comply with Section 16 reporting requirements.
The Form 4 documents exercise mechanics for SARs expiring 11/06/2025 and provides prices, share counts, and resulting ownership. It notes the typical net-share/cash settlement structure where 229 shares were issued and 981 were settled as the cash equivalent. The signature by an attorney-in-fact is provided. From a governance perspective, the filing transparently reports director transactions and updated beneficial ownership to 4,861 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 400 | $95.98 | $38K |
| Exercise | Stock Appreciation Rights (SARs) | 1,210 | $0.00 | -- |
| Exercise | Common Stock | 1,210 | $76.87 | $93K |
| Disposition | Common Stock | 981 | $94.83 | $93K |
| Sale | Common Stock | 229 | $94.83 | $22K |
Footnotes (1)
- Represents the exercise of Stock Appreciation Rights ("SARs") expiring on November 6, 2025, for which the reporting person exercised all 1,210 shares. This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (229). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($94.83) and the exercise price ($76.87).
